Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2023 Filed Jan 31, 2023 18:58 UTC |
McAlevey Michael RSVP & Chief Legal Officer
|
Exercise / conversionCommon Stock | 1,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-005806 · doc4.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 19:03 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 6,000 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-23-004910 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 Underlying: Common Stock · 6,000 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 19:03 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 2,966 | $263.81 | $782,460.46 |
DisclosureSEC source: 0001209191-23-004910 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,146 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 19:03 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 6,000 | $81.96 | $491,760.00 |
DisclosureSEC source: 0001209191-23-004910 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 17:38 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 10,000 | $224.07 | $2,240,690.00 |
DisclosureSEC source: 0001209191-22-057100 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,807 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.00 to $224.39, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 17:37 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 12,000 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-22-057098 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,880 Underlying: Common Stock · 12,000 shares Expires 2030-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 17:37 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 9,440 | $224.08 | $2,115,315.20 |
DisclosureSEC source: 0001209191-22-057098 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,443 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 17:37 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 12,000 | $145.24 | $1,742,880.00 |
DisclosureSEC source: 0001209191-22-057098 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2022 Filed Feb 1, 2023 20:05 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006041 · doc4.xml · nonDerivative · entry 3 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,527 Read SEC document |
| October 31, 2022 Filed Feb 1, 2023 19:57 UTC |
Cuffe Michael S.EVP and Chief Clinical Officer
|
GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006031 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,822.5543 F1 · balance_after: Includes 2,330.5543 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| October 28, 2022 Filed Oct 28, 2022 18:07 UTC |
Billington Phillip GSVP-Internal Audit Services
|
SaleCommon Stock | 8,332 | $222.58 | $1,854,518.23 |
DisclosureSEC source: 0001209191-22-054854 · doc4.xml · nonDerivative · entry 3 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,652.1056 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.50 to $222.77, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 2,176.1056 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:32 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 21,997 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001209191-22-055127 · doc4.xml · derivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,333 Underlying: Common Stock · 21,997 shares Expires 2029-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:32 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 9,150 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-22-055127 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,150 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:32 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 9,838 | $223.50 | $2,198,793.00 |
DisclosureSEC source: 0001209191-22-055127 · doc4.xml · nonDerivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,883 Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:32 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 23,064 | $223.66 | $5,158,494.24 |
DisclosureSEC source: 0001209191-22-055127 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,721 Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:32 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 21,997 | $139.06 | $3,058,902.82 |
DisclosureSEC source: 0001209191-22-055127 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:32 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 9,150 | $101.16 | $925,614.00 |
DisclosureSEC source: 0001209191-22-055127 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:30 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
SaleCommon Stock | 12,946 | $223.18 | $2,889,303.82 |
DisclosureSEC source: 0001209191-22-055125 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.00 to $223.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 17:54 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionStock Appreciation Right · Derivative | 35,625 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-22-054929 · doc4.xml · derivative · entry 9 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,625 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 17:54 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Tax withholdingCommon Stock | 17,709 | $217.77 | $3,856,488.93 |
DisclosureSEC source: 0001209191-22-054929 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,807 Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 17:54 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 35,625 | $37.18 | $1,324,537.50 |
DisclosureSEC source: 0001209191-22-054929 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 18:07 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Exercise / conversionStock Appreciation Right · Derivative | 8,075 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-22-054854 · doc4.xml · derivative · entry 5 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,075 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 18:07 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Exercise / conversionStock Appreciation Right · Derivative | 8,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-22-054854 · doc4.xml · derivative · entry 4 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 18:07 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Tax withholdingCommon Stock | 8,243 | $217.48 | $1,792,687.64 |
DisclosureSEC source: 0001209191-22-054854 · doc4.xml · nonDerivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,984.1056 F1 · balance_after: Includes 2,176.1056 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 18:07 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Exercise / conversionCommon Stock | 16,575 | $37.18 | $616,258.50 |
DisclosureSEC source: 0001209191-22-054854 · doc4.xml · nonDerivative · entry 1 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,227.1056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,176.1056 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 27,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · derivative · entry 8 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Tax withholdingCommon Stock | 14,554 | $214.40 | $3,120,377.60 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,946 Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Exercise / conversionCommon Stock | 27,500 | $47.97 | $1,319,175.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 5 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GiftCommon Stock | 3,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 29,771 Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 18:22 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 300 | $209.94 | $62,982.00 |
DisclosureSEC source: 0001209191-22-054668 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,372 Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 18:22 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 1,700 | $202.13 | $343,623.38 |
DisclosureSEC source: 0001209191-22-054668 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,672 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.08 to $202.395, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 10, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GiftCommon Stock | 17,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 33,371 Read SEC document |
| August 10, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GiftCommon Stock | 17,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 04, 2022 Filed Oct 27, 2022 18:51 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 16,320 Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 20:16 UTC |
Elcan Patricia F10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 325 | $198.66 | $64,564.50 |
DisclosureSEC source: 0001209191-22-043317 · doc4.xml · nonDerivative · entry 1 Elcan Patricia F · CIK 0001433376 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly by Spouse Disclosed balance after: 89,337.0149 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein. F2 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of 5,031 shares of common stock of HCA Healthcare, Inc. through an indirect pecuniary interest in such shares held by her spouse. In addition, the Reporting Person may be deemed to have indirect beneficial ownership in respect of 84,306.0149 units of Hercules, through an indirect pecuniary interest in such units held by her spouse, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 13, 2022 Filed May 17, 2022 17:40 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
SaleCommon Stock | 2,358 | $218.87 | $516,086.50 |
DisclosureSEC source: 0001209191-22-029783 · doc4.xml · nonDerivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,392 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.862 to $218.91, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2022 Filed Feb 1, 2023 20:05 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 18,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006041 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 18,640 Read SEC document |
| May 10, 2022 Filed Feb 1, 2023 20:05 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 18,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006041 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Indirect · By 2020 GRAT Disclosed balance after: 0 Read SEC document |
| May 03, 2022 Filed May 5, 2022 17:05 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
SaleCommon Stock | 500 | $215.38 | $107,690.00 |
DisclosureSEC source: 0001209191-22-027398 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,373 Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 7,577 | $215.29 | $1,631,278.85 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 7 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,955 F7 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $215.05 to $215.71, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 12,170 | $214.48 | $2,610,270.28 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 6 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,378 F6 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $214.00 to $214.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 7,683 | $213.47 | $1,640,066.96 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 5 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,208 F5 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $213.02 to $213.98, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 3,606 | $212.60 | $766,631.63 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 4 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,525 F4 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $212.06 to $212.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 16,313 | $211.22 | $3,445,589.45 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 3 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,919 F3 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $211.00 to $211.89, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 37,623 | $210.60 | $7,923,403.80 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 2 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,606 F2 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $210.00 to $210.99, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC |
FRIST THOMAS F JR10% owner
|
PurchaseCommon Stock, par value $0.01 per share | 4,128 | $209.73 | $865,760.49 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,983 F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $209.40 to $209.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2022 Filed May 3, 2022 17:59 UTC |
McAlevey Michael RSVP & Chief Legal Officer
|
PurchaseCommon Stock | 1,110 | $218.56 | $242,602.04 |
DisclosureSEC source: 0001209191-22-026849 · doc4.xml · nonDerivative · entry 1 McAlevey Michael R · CIK 0001907875 · SVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $218.10 to $218.90, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2022 Filed May 2, 2022 18:01 UTC |
Smith Andrea BDirector
|
PurchaseCommon Stock | 1,160 | $213.63 | $247,815.32 |
DisclosureSEC source: 0001209191-22-026463 · doc4.xml · nonDerivative · entry 1 Smith Andrea B · CIK 0001649634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,239 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $213.23 to $213.73, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:31 UTC |
Johnston Hugh FDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025874 · doc4.xml · nonDerivative · entry 1 Johnston Hugh F · CIK 0001377489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:34 UTC |
Smith Andrea BDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025878 · doc4.xml · nonDerivative · entry 1 Smith Andrea B · CIK 0001649634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,079 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.